BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 24611903)

  • 1. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
    Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
    J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme.
    Tayel A; Abd El Galil KH; Ebrahim MA; Ibrahim AS; El-Gayar AM; Al-Gayyar MM
    Eur J Pharmacol; 2014 Apr; 728():151-60. PubMed ID: 24530413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers.
    Elewa MA; Al-Gayyar MM; Schaalan MF; Abd El Galil KH; Ebrahim MA; El-Shishtawy MM
    Clin Exp Metastasis; 2015 Jun; 32(5):479-93. PubMed ID: 25999065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of epigallocatechin-3-gallate on the invasiveness of hepatocarcinoma cells in vitro].
    Lu L; Liu HM; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):825-7. PubMed ID: 18357659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine‑induced liver cancer via inhibition of cell division cycle 25A.
    Tang Y; Cao J; Cai Z; An H; Li Y; Peng Y; Chen N; Luo A; Tao H; Li K
    Mol Med Rep; 2020 Nov; 22(5):3873-3885. PubMed ID: 33000276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
    Zaghloul RA; El-Shishtawy MM; El Galil KH; Ebrahim MA; Metwaly AA; Al-Gayyar MM
    Eur J Pharmacol; 2015 Jan; 746():353-62. PubMed ID: 25449037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet.
    Chen N; Bezzina R; Hinch E; Lewandowski PA; Cameron-Smith D; Mathai ML; Jois M; Sinclair AJ; Begg DP; Wark JD; Weisinger HS; Weisinger RS
    Nutr Res; 2009 Nov; 29(11):784-93. PubMed ID: 19932867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
    Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel chemotherapeutic and renal protective effects for the green tea (EGCG): role of oxidative stress and inflammatory-cytokine signaling.
    El-Mowafy AM; Al-Gayyar MM; Salem HA; El-Mesery ME; Darweish MM
    Phytomedicine; 2010 Dec; 17(14):1067-75. PubMed ID: 20851589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro.
    Alyoussef A; Al-Gayyar MMH
    Biomed Pharmacother; 2018 Jul; 103():362-372. PubMed ID: 29669302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma.
    Al-Gayyar MM; Abbas A; Hamdan AM
    Biol Chem; 2016 Mar; 397(3):257-67. PubMed ID: 26733159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenolic phytochemicals derived from red pine (Pinus densiflora) inhibit the invasion and migration of SK-Hep-1 human hepatocellular carcinoma cells.
    Lee SJ; Lee KW; Hur HJ; Chun JY; Kim SY; Lee HJ
    Ann N Y Acad Sci; 2007 Jan; 1095():536-44. PubMed ID: 17404067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epigallocatechin-3-gallate induces apoptosis in human hepatocellular carcinoma cells].
    Chen XL; Wang Q; Cao LQ; Huang XH; Fu XH; Tan HX; Zhen MC; Chen JS
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2524-8. PubMed ID: 19080641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive and anti-cancer properties of the aqueous extract of flowers of Butea monosperma.
    Choedon T; Shukla SK; Kumar V
    J Ethnopharmacol; 2010 May; 129(2):208-13. PubMed ID: 20307637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro.
    Jin J; Chang Y; Wei W; He YF; Hu SS; Wang D; Wu YJ
    Acta Pharmacol Sin; 2012 May; 33(5):701-9. PubMed ID: 22555372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet.
    Ramesh E; Elanchezhian R; Sakthivel M; Jayakumar T; Senthil Kumar RS; Geraldine P; Thomas PA
    Fundam Clin Pharmacol; 2008 Jun; 22(3):275-84. PubMed ID: 18485145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals.
    Abou El Naga RN; Azab SS; El-Demerdash E; Shaarawy S; El-Merzabani M; Ammar el-SM
    Life Sci; 2013 Mar; 92(10):555-61. PubMed ID: 23352978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway.
    Hassoun SM; Abdel-Rahman N; Eladl EI; El-Shishtawy MM
    Tumour Biol; 2017 Jun; 39(6):1010428317707376. PubMed ID: 28651490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
    Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
    Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells.
    Zhang Y; Owusu L; Duan W; Jiang T; Zang S; Ahmed A; Xin Y
    Int J Mol Med; 2013 Oct; 32(4):959-64. PubMed ID: 23863984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.